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Operative Time Less Than 1.5 Hours, Male Sex,
Dependent Functional Status, Presence of Dyspnea,
and Reoperations Within 30 days Are Independent
Risk Factors for Readmission After ACLR
Connor R. Crutchﬁeld, B.A., Jack R. Zhong, M.D., Nathan J. Lee, M.D.,
Thomas A. Fortney, M.D., Christopher S. Ahmad, M.D., and T. Sean Lynch, M.D.

Purpose: The purposes of this study are to use a large, patient-centered database to describe the 30-day readmission rate
and to identify predictive risk factors for readmission after elective isolated ACLR. Methods: The National Surgical
Quality Improvement Program Database was retrospectively queried for isolated ACLR procedures between 2011 and
2017. Current Procedural Terminology (CPT) codes were used to identify isolated ACLR patients. Those undergoing
additional procedures such as meniscectomy or multi-ligamentous reconstruction were excluded. Readmissions were
analyzed against demographic variables with bivariate analysis. Multivariate logistic regression was used to ﬁnd independent risk factors for 30-day readmissions after ACLR. Results: A total of 11,060 patients (37.2% female) were
included with an average age of 32.2  10.6 years and mean body mass index (BMI) of 27.9  6.5 kg/m2 (29.2% were
>30). The overall readmission rate was 0.59%. The most reported reason for readmission was infection 0.22 (24 out of
11,060). The following variables were associated with signiﬁcantly higher readmission rates: male sex (P ¼ .001), history
of severe chronic obstructive pulmonary disease (COPD) (P ¼ .025), cardiac comorbidity (P ¼ .034), operative time >1.5
hours (P <.001), partially dependent functional health status (P ¼ .002), high preoperative creatinine (P ¼ .009), normal
preoperative albumin (P ¼ .020), hypertension (P ¼ .034), and reoperations (P < .001). Operative time >1.5 hours, male
sex, dependent functional status, the presence of dyspnea, and undergoing a reoperation were identiﬁed as independent
risk factors for 30-day readmissions (P < .05 for all). Conclusions: Isolated ACLR is associated with low 30-day readmission rates. Operative time >1.5 hours, male sex, dependent functional status, the presence of dyspnea, and 30-day
reoperations are independent risk factors for readmission that should be considered in patient selection and addressed
with preoperative counseling. Level of Evidence: Level III, retrospective cohort study.
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Introduction

A

nterior cruciate ligament (ACL) ruptures are the
most common ligament injury in the United
States and one of the most frequent knee injuries
overall.1,2 Because of the poor healing response of the
torn ligament, ACL reconstruction (ACLR) is also one of
the most commonly performed sports medicine procedures with estimates ranging from 200,000 to
300,000 surgeries annually.3-5 Isolated ACL tears,
deﬁned as tears without concomitant ligament injury,
have been reported with a similar incidence.6 ACLR has
been established as a safe and effective outpatient
procedure, and the factors contributing to its short- and
long-term outcomes have been studied extensively.3,7-10 However, despite the current health care
system’s shift toward outcome-based practices, the rates
of short-term readmission after isolated ACLR are
unclear.
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A 2004 study found that hospital readmissions
accounted for $17.4 billion of the annual $102 billion of
Medicare expenditures.11 This led to a proliferation in
the study of postsurgical readmissions in orthopedics, as
rehospitalizations became an important target for
health care cost reduction.12-26 Since the introduction
of the Hospital Readmissions Reduction Program to the
Social Security Act in 2012, health care payers and the
Centers for Medicare and Medicaid Services have
focused on unplanned readmissions and levied ﬁnancial penalties for those deemed preventable.27 Therefore, physicians must be cognizant of the impact of
postsurgical readmissions on hospital costs, as well as
the patient experience.
The estimated annual cost of ACLR to the healthcare
system is $2 billion28; however, this estimate does not
consider the impact of postsurgical hospital readmissions. Therefore, this is likely to be a conservative
projection of the true ﬁnancial impact of ACLR procedures. Currently, several studies have investigated
the risk factors in ACLR, overnight admissions after
isolated ACLR, and readmission rates in other types of
knee surgery.3,7,9,29 Bokshan et al. performed a retrospective study of 9,146 patients undergoing ACLR and
found that Hispanic ethnicity, use of epidural anesthesia, a known bleeding disorder, increased body mass
index (BMI), longer operation time, and younger age
were all independently associated with readmissions
after surgery.3 In another study of 14,159 isolated
ACLRs focused on the effect of increased operative
times, a 15-minute increase led to signiﬁcantly higher
rates of readmission, postoperative complications, and
extended lengths of stay in the hospital.7 More recently,
Min et al. performed a similar study of 20,819 standard
ACLR patients and used multivariate regressions to
determine that regional anesthesia alone, increasing
concurrent procedures, and obesity contributed to
hospital readmissions in the immediate postoperative
period.9 They also found that the same risk factors
applied to their smaller subgroup analysis of isolated
ACLRs.9 To our knowledge, only this minor subanalysis
reporting on hospital readmissions after isolated ACLR
exist in the current literature.9,15 The purposes of this
study are to use a large, patient-centered database to
describe the 30-day readmission rate and to identify
predictive risk factors for readmission after elective
isolated ACLR. We hypothesize that rates of readmission will be low and that obesity, surgical duration,
and an increased number of comorbidities will be
contributing risk factors.

interval during which readmission data were collected.
The American College of Surgeons National Surgical
Quality Improvement Program database ACS-NSQIP is
a deidentiﬁed database with information on procedure
type and outcomes data from 684 hospitals across the
United States.30 Current Procedural Terminology (CPT)
codes were used to identify elective knee arthroscopies
involving ACLR. The CPT code, 29888, was then used
to identify isolated ACLR cases. Surgeries involving
concomitant procedures such as meniscectomy or
multiligamentous reconstruction were excluded. CPT
codes used for patient identiﬁcation are provided in a
complete list in Table 1.

Methods

Retrospective analysis of the ACS-NSQIP database
identiﬁed 11,060 patients (37.2% female) that met the
eligibility criteria of undergoing an isolated ACLR between 2011 and 2017. The mean age of included patients was 32.2  10.6 years and the average body mass

Variables Collected
Demographic information retrieved from the ACSNSQIP included age, sex, race, ethnicity, and inpatient/outpatient status. Age was categorized into ﬁve
groups (16-20, 21-30, 31-40, 41-50, and >50). Patient
variables were recorded, including body mass index,
American Society of Anesthesiologist (ASA) class, diabetes, dyspnea, chronic obstructive pulmonary disease
(COPD), hypertension, renal disease, heart disease,
smoking history, alcohol intake, bleeding disorders,
functional health status, steroid use, and recent weight
loss. Examined laboratory values included hematocrit,
creatinine, and serum albumin. Perioperative factors,
including principal anesthesia technique and operative
time, were recorded. Thirty-day reoperation and 30day readmission rates were compiled from International Classiﬁcation of Diseases (ICD) 9/10 codes along
with frequency of readmission. Readmissions were
deﬁned as postoperative hospital admissions related to
and within 30-days of the index isolated ACLR
procedure.
Statistical Analysis
Bivariate analysis of the collected demographics, patient variables, laboratory values, and perioperative
factors was conducted against the isolated ACLR cases
that resulted in a readmission. Categorical comparisons
between variables were then made using chi-squared
tests. Finally, multivariate logistic regression was used
to ﬁnd independent risk factors for readmission after
ACLR by calculating odds ratios (OR) and 95% conﬁdence intervals (CI). All statistical analyses were conducted using SAS 9.2 software (SAS Institute Inc., Cary,
NC), and the alpha was set at P < .05 to deﬁne
signiﬁcance.

Results
In December 2019, the American College of Surgeons
National Surgical Quality Improvement Program database (ACS-NSQIP) was queried for isolated ACLR procedures between 2011 and 2017, as this was the only
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Table 1. Deﬁnitions of the CPT Codes for NSQIP Query
CPT Code
29888
27403
29868
29880
29881
29882
29883
29889
27557
27558
27412
27415
29877
29885
29886
29887
29879
29866
29867
27405
27409

Deﬁnition
Arthroscopically aided anterior cruciate ligament repair/augmentation or
reconstruction
Arthrotomy with meniscus repair, knee
Arthroscopy, knee, surgical; meniscal transplantation (includes arthrotomy for
meniscal insertion)
Arthroscopy, knee, surgical; with meniscectomy (medial AND lateral, including any
meniscal
Arthroscopy, knee, surgical; with meniscectomy (medial OR lateral, including any
meniscal shaving)
Arthroscopy, knee, surgical; with meniscus repair (medial OR lateral)
Arthroscopy, knee, surgical; with meniscus repair (medial AND lateral)
Arthroscopically aided posterior cruciate ligament repair/augmentation or
reconstruction
Open treatment of knee dislocation, with or without internal or external ﬁxation;
with primary ligamentous repair
Open treatment of knee dislocation, with or without internal or external ﬁxation;
with primary ligamentous repair, with augmentation/reconstruction
Autologous chondrocyte implantation, knee
Osteochondral allograft, knee, open
Arthroscopy, knee, surgical; debridement/shaving of articular cartilage
(chondroplasty)
Arthroscopy, knee, surgical; drilling for osteochondritis dissecans with bone grafting,
with or without internal ﬁxation (including debridement of base of lesion)
Arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion
Arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion with
internal ﬁxation
Arthroscopy, knee, surgical; abrasion arthroplasty (includes chondroplasty where
necessary)
Arthroscopy, knee, surgical; osteochondral autograft(s) (e.g., mosaicplasty) (includes
harvesting of the autograft(s)
Arthroscopy, knee, surgical; osteochondral allograft (e.g., mosaicplasty)
Repair, primary, torn ligament and/or capsule, knee; collateral
Repair, primary, torn ligament and/or capsule, knee; collateral and cruciate ligaments

Included or Excluded
Included
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded
Excluded

CPT, Current Procedural Terminology.

index (BMI) was 27.9  6.5 kg/m2 with 29.2% of patients having a BMI > 30. Of the total patient cohort, 65
(0.59%) were readmitted within 30 days of the index
surgery, and the most frequent reason for readmission
was postoperative infection (0.22%). A complete list of
reported reasons for readmissions is presented in
Table 2, while rates of readmission have been differentiated by year in Table 3 and reproduced graphically
using a Cochran-Armitage Trend Test in Fig 1. Readmission rates were not signiﬁcantly associated with year
(P ¼ .315).
Bivariate analysis revealed that the following patient
characteristics was signiﬁcantly associated with higher
readmission rates: male sex (P ¼ .001), history of severe
COPD (P ¼ .025), cardiac comorbidity (P ¼ .034),
operative time >1.5 hours (P < .001), partially dependent functional health status preoperatively (P ¼ .002),
high preoperative creatinine (P ¼ .009), normal preoperative albumin (P ¼ .02), history of hypertension
(P ¼ .034), and undergoing a reoperation (P < .001)
(Table 4). Multivariate analysis determined that operative time >1.5 hours (P < .05), male sex (P < .05),

dependent functional status (P > .005), the presence of
dyspnea (P < .05) and undergoing a reoperation within
30 days of the index procedure (P < .001) were all
independent risk factors for 30-day readmission after
ACLR (Table 5).

Discussion
In this study, we found that 30-day readmission rates
were low at just 0.59% of patients. Within that cohort,
operative time >1.5 hours, male sex, dependent functional status, the presence of dyspnea, and undergoing
a reoperation within 30 days of the index procedure
were identiﬁed as independent risk factors for readmission after ACLR using multivariate logistic analysis.
Notably, postsurgical infection was the most common
cause of readmission and bivariate analysis associated
male sex, history of severe COPD, cardiac comorbidity,
operative time >1.5 hours, partially dependent preoperative functional health status, high preoperative
creatinine, normal preoperative serum albumin, history
of hypertension, and 30-day reoperations with an
increased likelihood for readmission.
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Table 2. Reported Reasons for 30-Day Readmission After
Isolated ACLR and Their Incidence rates.

Table 3. A Summary of 30-Day Isolated ACLR Readmission
Rates by Year From 2011 to 2017

Readmission Reasons
Infection of Any Type
Deep Infection
Organ/Space Infection
Superﬁcial Infection
Graft-Related Infection
Abscess/Furuncle/Carbuncle
Cellulitis
Unspeciﬁed Infection
Venous Thromboembolism
Vein Thrombosis requiring Therapy
DVT Requiring Therapy
Pulmonary Embolism
Structural and Stability Problems
Disruption of ACL
Hematoma
Effusion
Joint instability
Sprain of ACL
Intestinal Obstruction
Hiccough
Atelectasis
Ankylosis
Dermatitis
Residual Pain
Other
Not Readmitted
Total

Operative Year
2011
2012
2013
2014
2015
2016
2017

Frequency
24
8
7
5
1
1
1
1
12
6
2
4
29
1
1
3
1
1
1
1
1
1
1
6
11
10995
11060

Percentage (%)
0.22
0.07
0.06
0.05
0.01
0.01
0.01
0.01
0.11
0.05
0.02
0.04
0.26
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.10
99.41
100.00

As hypothesized, surgical duration and number of
comorbidities were identiﬁed as risk factors for ACLR
readmission. Obesity, however, was not predictive of
readmission in this analysis. This result contrasts with
our hypothesis as well as the ﬁndings of a recent study
by Cooper et al. in which obesity was, in fact,

Readmission Rate (%)
0.38
0.93
0.48
0.24
0.71
0.64
0.63

determined to be a predictive risk factor for ACLR
readmission.15 However, two important distinctions
exist between our study methodologies. First, Cooper
et al. investigated all elective ACLR cases in their
readmission analysis, not just isolated ACLR. The inclusion of concomitant procedures may have impacted
operative times, and therefore, complication and readmission rates, confounding the results. Second, in a
multivariate analysis, Cooper et al. found a BMI  40
(class III) to be predictive of readmission. While the
authors concluded that obesity is a risk factor for ACLR
readmission, BMI >40 is often classiﬁed as morbid
obesity.15 By contrast, our analysis used a BMI of  30
(classes I-III) to report obesity without substratiﬁcation
by class. Our larger study size and inclusion of BMI 
30 allowed us to capture far more obese patients (3,224
vs 46) and provides a more complete assessment of the
effect of obesity on isolated ACLR readmission rates.
Currently, the knee arthroplasty and arthroscopy
literature is conﬂicted in establishing patient obesity as
a predictive factor of readmissions,8,13,15,21,31-33 but it is
well known that obesity is associated with increased
surgical times and postoperative complications, and so

Fig 1. Cochran-Armitage Trend Test of 30day readmission rates from 2011-2017
indicated no signiﬁcant relationship between readmission rate and year (P ¼
.3145).
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Table 4. Bivariate Analysis of ACLR Patient Demographics by Readmission Status
Readmission Bivariate Analysis
Age Group
16-20
21-30
31-40
41-50
>50
Sex
Female
Male
Race
American Indian or Alaska Native
Asian
Black or African American
Hispanic
Native Hawaiian or Paciﬁc Islander
White
Other/Not Reported
Hispanic Ethnicity
Yes
No
Unknown
NULL
Obese
No
Yes
ASA
3
>3
Diabetes
No
Yes
History of severe COPD
No
Yes
Current smoker within one year
No
Yes
Cardiac comorbidity
No
Yes
Renal comorbidity
No
Yes
Bleeding disorders
No
Yes
Inpatient/outpatient
Inpatient
Outpatient
Operative Time
1.5 hours
>1.5 hours
Functional health status prior to surgery
Independent
Partially Dependent
Unknown
Steroid use for chronic condition
No
Yes
>10% loss body weight in last 6 months
No
Yes

No (n ¼ 10995)

Yes (n ¼ 65)

Total (n ¼ 11060)

1335 (99.8%)
4294 (99.4%)
2927 (99.2%)
1743 (99.5%)
696 (99.6%)

3 (0.2%)
25 (0.6%)
25 (0.8%)
9 (0.5%)
3 (0.4%)

1338 (12.1%)
4319 (39.1%)
2952 (26.7%)
1752 (15.8%)
699 (6.3%)

4108 (99.7%)
6887 (99.2%)

11 (0.3%)
54 (0.8%)

4119 (37.2%)
6941 (62.8%)

P Value
.1421

.0011

.3601
173 (100.0%)
533 (99.8%)
941 (99.2%)
882 (99.0%)
133 (99.3%)
5475 (99.4%)
2858 (99.5%)

0 (0.0%)
1 (0.2%)
8 (0.8%)
9 (1.0%)
1 (0.7%)
31 (0.6%)
15 (0.5%)

173 (1.6%)
534 (4.8%)
949 (8.6%)
891 (8.1%)
134 (1.2%)
5506 (49.8%)
2873 (26.0%)
.2411

1030 (99.0%)
6805 (99.5%)
2760 (99.5%)
400 (99.0%)

10 (1.0%)
37 (0.5%)
14 (0.5%)
4 (1.0%)

1040 (9.4%)
6842 (61.9%)
2774 (25.1%)
404 (3.7%)

7794 (99.5%)
3201 (99.3%)

42 (0.5%)
23 (0.7%)

7836 (70.8%)
3224 (29.2%)

.2671

.5201
10501 (99.4%)
494 (99.2%)

61 (0.6%)
4 (0.8%)

10562 (95.5%)
498 (4.5%)

10827 (99.4%)
168 (100.0%)

65 (0.6%)
0 (0.0%)

10892 (98.5%)
168 (1.5%)

.3151

.0251
10971 (99.4%)
24 (96.0%)

64 (0.6%)
1 (4.0%)

11035 (99.8%)
25 (0.2%)

9062 (99.4%)
1933 (99.3%)

51 (0.6%)
14 (0.7%)

9113 (82.4%)
1947 (17.6%)

.4041

.0341
10334 (99.5%)
661 (98.8%)

57 (0.5%)
8 (1.2%)

10391 (94.0%)
669 (6.0%)

10993 (99.4%)
2 (100.0%)

65 (0.6%)
0 (0.0%)

11058 (100.0%)
2 (0.0%)

10972 (99.4%)
23 (100.0%)

65 (0.6%)
0 (0.0%)

11037 (99.8%)
23 (0.2%)

640 (98.9%)
10355 (99.4%)

7 (1.1%)
58 (0.6%)

647 (5.8%)
10413 (94.2%)

5271 (99.7%)
5724 (99.2%)

16 (0.3%)
49 (0.8%)

5287 (47.8%)
5773 (52.2%)

10887 (99.4%)
16 (94.1%)
92 (97.9%)

62 (0.6%)
1 (5.9%)
2 (2.1%)

10949 (99.0%)
17 (0.2%)
94 (0.8%)

.9131

.7121

.0901

<.0011
.0021

.0791
10961 (99.4%)
34 (97.1%)

64 (0.6%)
1 (2.9%)

11025 (99.7%)
35 (0.3%)

10986 (99.4%)
9 (100.0%)

65 (0.6%)
0 (0.0%)

11051 (99.9%)
9 (0.1%)

.8181

(continued)
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Table 4. Continued
Readmission Bivariate Analysis
EtOH > 2 drinks/day in 2 weeks before admission
No
Yes
NULL
Missing
Hematocrit level
Low (<35.5%)
Normal
Null
Creatinine level
High (>1.21)
Normal
Null
Albumin level
Low (<3.4)
Normal
Null
Principal anesthesia technique
Epidural
General
MAC/IV Sedation
Regional
Spinal
Other
Unknown
Reoperation within 30-days of index procedure
No
Yes
Hypertension requiring medication
No
Yes

No (n ¼ 10995)

Yes (n ¼ 65)

Total (n ¼ 11060)

673 (99.3%)
10 (100.0%)
3384 (99.6%)
6928 (99.3%)

5 (0.7%)
0 (0.0%)
14 (0.4%)
46 (0.7%)

678 (6.1%)
10 (0.1%)
3398 (30.7%)
6974 (63.1%)

P Value
.5121

.1341
125 (100.0%)
3083 (99.2%)
7787 (99.5%)

0 (0.0%)
25 (0.8%)
40 (0.5%)

125 (1.1%)
3108 (28.1%)
7827 (70.8%)
.0091

101 (97.1%)
2355 (99.4%)
8539 (99.4%)

3 (2.9%)
14 (0.6%)
48 (0.6%)

104 (0.9%)
2369 (21.4%)
8587 (77.6%)
.0201

18 (100.0%)
956 (98.8%)
10021 (99.5%)

0 (0.0%)
12 (1.2%)
53 (0.5%)

18 (0.2%)
968 (8.8%)
10074 (91.1%)
.9601

22 (100.0%)
10372 (99.4%)
120 (100.0%)
145 (99.3%)
328 (99.1%)
6 (100.0%)
2 (100.0%)

0 (0.0%)
61 (0.6%)
0 (0.0%)
1 (0.7%)
3 (0.9%)
0 (0.0%)
0 (0.0%)

22 (0.2%)
10433 (94.3%)
120 (1.1%)
146 (1.3%)
331 (3.0%)
6 (0.1%)
2 (0.0%)
<.0011

10971 (99.7%)
24 (45.3%)

36 (0.3%)
29 (54.7%)

11007 (99.5%)
53 (0.5%)

10334 (99.5%)
661 (98.8%)

57 (0.5%)
8 (1.2%)

10391 (94.0%)
669 (6.0%)

.0341

Signiﬁcantly different values are in bold.
1
Chi-square

further study of this particular variable is warranted for
this procedure.
Regarding the variables that were identiﬁed as predictors of readmissiondoperative time >1.5 hours,
male sex, dependent functional status, the presence of
dyspnea, and 30-day reoperationsdthese ﬁndings are
consistent with what has been previously reported in
the orthopedic literature. Longer procedural times have
been repeatedly associated with an increase in postsurgical complications and occasionally with readmissions.3,7,15 Meanwhile, the high predictive
signiﬁcance of 30-day reoperations indicates that the
majority of such procedures required hospital admission in this cohort. Male sex has also been linked to a
greater number of intra-articular pathologies in
ACLR,34 which may then translate to longer OR times.
Additional systemic comorbidities and older age have
been known to complicate surgeries as well and may
require more involved perioperative management.9,35-37 However, age was not signiﬁcantly associated with ACLR readmission rates in our study. The
effects of age on short-term ACLR outcomes may be

better elucidated by future investigations of graft choice
in varying age groups, especially since allografts tend to
be favored in older ACLR patients. Although conﬂicting
evidence exists regarding other demographic factors
such as race and ethnicity, our results support previous
studies that have found no signiﬁcance in their predictive capacities in ACLR outcomes8,29,38-40 or postoperative readmissions.15
Finally, readmissions for a procedure performed as
commonly as ACLR are likely to be one contributor to
hospital costs and may extend into the tens of millions
of dollars when averaged annually across the United
States. Although the average readmission rate found in
this study was low (0.59%), this could amount to
nearly 1,800 readmission events in the United States
each year based on the estimated 300,000 ACLR procedures performed annually. Given its frequency,
ACLR is a valuable target for studies aiming to identify
predictive factors of postsurgical readmissions with the
goal of preventing adverse events, maximizing hospital
reimbursements, and improving patient outcomes.
Although prior studies have investigated overnight

PREDICTORS OF ISOLATED ACLR READMISSIONS
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Table 5. Multivariate Logistic Regression for Predictive Factors of Readmission After Isolated ACLR
Outcome
Age group
16-20
21-30
31-40
41-50
>50
Operative time >1.5 hours
Non-White race
BMI <30
Smoker within 1 year
Dyspnea
Male sex
Partially dependent Functional status
Steroid use for a chronic condition
No cardiac comorbidity
No history of COPD
ASA >3
Low hematocrit
High creatinine
Low albumin
Use of general anesthesia
Reoperation within 30 days of index procedure
Hypertension requiring medication

Odds Ratio (95% Conﬁdence Interval)
Reference
2.454 (0.739, 8.153)
3.881 (1.162, 12.962)
2.494 (0.652, 9.542)
1.899 (0.356, 10.121)
2.769 (1.554, 4.931)
1.080 (0.659, 1.777)
0.830 (0.441, 1.595)
1.317 (0.633, 2.595)
6.509 (1.324, 31.992)
0.358 (0.185, 0.694)
10.171 (1.203, 85.996)
5.934 (0.694, 50.750)
0.536 (0.235, 1.223)
0.372 (0.043, 9.299)
0.847 (0.220, 2.467)
0.551 (0.265, 1.183)
3.396 (0.736, 11.064)
0.572 (0.240, 1.403)
1.508 (0.474, 6.373)
478.711 (234.233, >999.999)
1.483 (0.499, 3.920)

P Value
.1237
.4724
.1454
.3485
.4210
.0298
.1766
.5680
.4403
.0454
.0284
.0049
.1356
.1060
.3177
.2244
.1167
.0685
.2118
.5313
<.0001
.4505

Operative time >1.5 hours, male sex, dependent functional status, presence of dyspnea, and a reoperation within 30 days of the index procedure were all independent risk factors for readmission. Signiﬁcant values in bold.

admissions after isolated ACLR, risk factors for readmission after isolated ACLR have not been described in
detail. A major strength of this study is the analysis of
more than 11,000 cases using a large, national, and
patient-centered database to identify pertinent patient
and procedural risk factors. The present study conﬁrms
some familiar variables as risk factors including longer
operative times, preoperative comorbidities, and male
sex, but also better characterizes the roles of other
variables debated in the literature, including obesity,
age, race, and ethnicity. These results may help surgeons identify patients at risk for readmission, guide
patient education, and improve perioperative management for those undergoing ACLR. Although not
possible in this analysis, further investigations of ACLR
readmissions by graft type and/or primary versus revision procedures, or predictors of PRO score quality in
isolated ACLR would be of great interest to this topic.
Limitations
This study is not without limitations. A signiﬁcant
limitation is the inability to determine the type of graft
or surgical technique used for each ACLR procedure
from the NSQIP database. Graft typedhamstring
autograft versus patellar bone-tendon-bone (BTB)
versus quadriceps autograft versus allograftdcan
signiﬁcantly inﬂuence operative times and has been
shown to affect surgical outcomes.41 In addition, the
preferred use of allografts in older ACLR patients may

have also affected the distribution of these ﬁndings.
Second, the NSQIP database does not record information regarding the details of perioperative care. When
one considers the variety of protocols and health care
professionals that are involved in presurgical administration to postoperative management, it is possible that
an event necessitating readmission could be initiated by
circumstances extending beyond the variables included
in this analysis. Finally, while the data of the NSQIP are
known to be of high quality, the data reviewed for this
study represent only a sample of ACLRs between 2011
and 2017. As a result, there is a gap of time between the
most recently collected data and the date of our retrospective query, which may be a source of bias. Similarly, the NSQIP does not encompass all surgical
settings, like independent surgical centers, and, therefore, may not be generalizable for all surgeons. This
analysis has provided a focused assessment of an
understudied outcome of isolated ACLR; however, a
paucity of information on this topic remains and should
continue to be investigated.
Conclusions
Isolated ACLR is associated with low 30-day readmission rates. Operative time >1.5 hours, male sex,
dependent functional status, the presence of dyspnea,
and 30-day reoperations are independent risk factors
for readmission that should be considered in patient
selection and addressed with preoperative counseling.
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